Quality of Life in Patients with Morphea: A Cross-Sectional Study and a Review of the Current Literature

Table 1

Demographic and clinical characteristics of the patient population.

	Morphea, (%)
Gender
Male	8 (12.3%)
Female	57 (87.7%)
Age
Clinical subtype of morphea
Plaque type	31 (47.7%)
Generalized type	15 (23.0%)
Linear type	3 (4.6%)
En coup de sabre	1 (1.5%)
Progressive facial hemiatrophy (Pary-Romberg syndrome)	2 (3.1%)
Atrophoderma of Pasini and Pierini (APP)	7 (10.8%)
Deep type	1 (1.5%)
Lichen sclerosus	5 (7.7%)
Autoimmune comorbidity
Yes	14 (21.5%)
No	51 (78.5%)
Autoimmune diseases in the family
Yes	14 (21.5%)
No	51 (78.5%)
Presence of antinuclear antibodies
Yes	18 (27.7%)
No	24 (36.9%)
Not assessed	23 (35.4%)